Circulating tumor DNA (ctDNA) is a promising biomarker for monitoring treatment response and progression-free survival in ...

Importantly, stomach cancer is also being diagnosed in an increasing number of younger people -- that is, those younger than 50. In 2019, these cancers -- also called early-onset -- accounted for ...

Received folinic acid/fluorouracil/oxaliplatin/bevacizumab in first line with initial partial response; progression after 11 ...

Inflammation was linked to fatigue among nearly 200 women with early-stage breast cancer during and after treatment with radiation or chemotherapy, researchers reported Oct. 6 in the journal Cancer.

Standard cancer screenings in the U.S. overlook nearly 70% of cancers and cancer subtypes. Multiple-cancer early detection (MCED) blood tests can help identify cancer biomarkers for multiple cancer ...

A team of researchers in California studied a new multi-cancer early detection test called Galleri, which can reportedly ...

Heal Squad' podcast host Maria Menounos, whose pancreatic cancer was discovered early enough to be treated, says, "If it ...

BERLIN -- Adding a test that predicts cancer signal origin to single standard of care (SoC) screening substantially increased ...

Teal Health is the first federally approved at-home cervical cancer screening. The Food and Drug Administration approved the ...

The Galleri test aims to find fragments of DNA in a person’s blood that can indicate the presence of a cancerous tumor.